Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 444, 175-187
Abstract
No abstract availableKeywords
Funding Information
- NIH (CA155477, MOHW104-TDU-B-212-113002)
- Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence
This publication has 48 references indexed in Scilit:
- New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cellsJournal of Molecular Cell Biology, 2012
- Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinomaDiagnostic Pathology, 2012
- Slug and Sox9 Cooperatively Determine the Mammary Stem Cell StateCell, 2012
- Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver CancerCell, 2012
- Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overviewJournal of Translational Medicine, 2011
- Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA TranscriptionScience Translational Medicine, 2010
- Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3β kinase pathways #Hepatology, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen levelProceedings of the National Academy of Sciences, 2007
- Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factorsThe International Journal of Biochemistry & Cell Biology, 2007